PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $8,071,000 | -69.6% | 8,067,000 | -65.0% | 7.78% | -63.4% |
| Q3 2018 | $26,578,000 | -5.5% | 23,067,000 | -17.8% | 21.23% | -30.2% |
| Q2 2018 | $28,135,000 | -35.7% | 28,067,000 | -39.7% | 30.42% | +13.5% |
| Q1 2018 | $43,752,000 | +19.2% | 46,567,000 | +2.2% | 26.79% | +23.4% |
| Q4 2017 | $36,690,000 | – | 45,567,000 | – | 21.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,067,000 | $8,071,000 | 7.78% |
| DeepCurrents Investment Group LLC | 5,000,000 | $4,975,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 27,439,000 | $27,337,000 | 0.33% |
| CSS LLC/IL | 3,000,000 | $2,993,000 | 0.20% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,130,000 | $23,602,000 | 0.17% |
| Allianz Asset Management GmbH | 30,570,000 | $30,097,000 | 0.03% |
| CREDIT SUISSE AG/ | 12,105,000 | $12,029,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 15,498,000 | $15,401,000 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 11,300,000 | $11,200,153,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 12,700,000 | $12,621,000 | 0.01% |